These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 17210678)
41. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells. Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983 [TBL] [Abstract][Full Text] [Related]
42. p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia. Link PA; Baer MR; James SR; Jones DA; Karpf AR Cancer Res; 2008 Nov; 68(22):9358-66. PubMed ID: 19010910 [TBL] [Abstract][Full Text] [Related]
43. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression. Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764 [TBL] [Abstract][Full Text] [Related]
44. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors. Lin ZP; Belcourt MF; Cory JG; Sartorelli AC J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505 [TBL] [Abstract][Full Text] [Related]
45. The fate of p21CDKN1A in cells surviving UV-irradiation. Itoh T; Linn S DNA Repair (Amst); 2005 Dec; 4(12):1457-62. PubMed ID: 16182613 [TBL] [Abstract][Full Text] [Related]
46. A low UVB dose, with the potential to trigger a protective p53-dependent gene program, increases the resilience of keratinocytes against future UVB insults. Decraene D; Smaers K; Maes D; Matsui M; Declercq L; Garmyn M J Invest Dermatol; 2005 Nov; 125(5):1026-31. PubMed ID: 16297205 [TBL] [Abstract][Full Text] [Related]
47. E2F1 regulates p53R2 gene expression in p53-deficient cells. Qi JJ; Liu L; Cao JX; An GS; Li SY; Li G; Jia HT; Ni JH Mol Cell Biochem; 2015 Jan; 399(1-2):179-88. PubMed ID: 25312903 [TBL] [Abstract][Full Text] [Related]
48. Acute renal failure during sepsis: potential role of cell cycle regulation. Yang QH; Liu DW; Long Y; Liu HZ; Chai WZ; Wang XT J Infect; 2009 Jun; 58(6):459-64. PubMed ID: 19428114 [TBL] [Abstract][Full Text] [Related]
49. Deoxyribonucleotide metabolism in cycling and resting human fibroblasts with a missense mutation in p53R2, a subunit of ribonucleotide reductase. Pontarin G; Ferraro P; Rampazzo C; Kollberg G; Holme E; Reichard P; Bianchi V J Biol Chem; 2011 Apr; 286(13):11132-40. PubMed ID: 21297166 [TBL] [Abstract][Full Text] [Related]
50. Determination of the potency and subunit-selectivity of ribonucleotide reductase inhibitors with a recombinant-holoenzyme-based in vitro assay. Shao J; Zhou B; Zhu L; Bilio AJ; Su L; Yuan YC; Ren S; Lien EJ; Shih J; Yen Y Biochem Pharmacol; 2005 Feb; 69(4):627-34. PubMed ID: 15670581 [TBL] [Abstract][Full Text] [Related]
51. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Le NT; Richardson DR Biochim Biophys Acta; 2002 Oct; 1603(1):31-46. PubMed ID: 12242109 [TBL] [Abstract][Full Text] [Related]
52. Hypersensitivity to chromium-induced DNA damage correlates with constitutive deregulation of upstream p53 kinases in p21-/- HCT116 colon cancer cells. Hill R; Leidal AM; Madureira PA; Gillis LD; Cochrane HK; Waisman DM; Chiu A; Lee PW DNA Repair (Amst); 2008 Feb; 7(2):239-52. PubMed ID: 18024214 [TBL] [Abstract][Full Text] [Related]
53. Tripeptidyl peptidase II plays a role in the radiation response of selected primary cell types but not based on nuclear translocation and p53 stabilization. Firat E; Tsurumi C; Gaedicke S; Huai J; Niedermann G Cancer Res; 2009 Apr; 69(8):3325-31. PubMed ID: 19351849 [TBL] [Abstract][Full Text] [Related]
54. Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage. Pontarin G; Fijolek A; Pizzo P; Ferraro P; Rampazzo C; Pozzan T; Thelander L; Reichard PA; Bianchi V Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17801-6. PubMed ID: 18997010 [TBL] [Abstract][Full Text] [Related]
55. Enzymatic property analysis of p53R2 subunit of human ribonucleotide reductase. Yen Y; Chu B; Yen C; Shih J; Zhou B Adv Enzyme Regul; 2006; 46():235-47. PubMed ID: 16846634 [No Abstract] [Full Text] [Related]
56. Akt and p53R2, partners that dictate the progression and invasiveness of cancer. Yousefi B; Samadi N; Ahmadi Y DNA Repair (Amst); 2014 Oct; 22():24-9. PubMed ID: 25086499 [TBL] [Abstract][Full Text] [Related]
57. Arecoline-induced growth arrest and p21WAF1 expression are dependent on p53 in rat hepatocytes. Chou WW; Guh JY; Tsai JF; Hwang CC; Chen HC; Huang JS; Yang YL; Hung WC; Chuang LY Toxicology; 2008 Jan; 243(1-2):1-10. PubMed ID: 17997002 [TBL] [Abstract][Full Text] [Related]
58. Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin. Azimi A; Majidinia M; Shafiei-Irannejad V; Jahanban-Esfahlan R; Ahmadi Y; Karimian A; Mir SM; Karami H; Yousefi B Gene; 2018 Feb; 642():249-255. PubMed ID: 29126924 [TBL] [Abstract][Full Text] [Related]
59. Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells. Pontarin G; Ferraro P; Bee L; Reichard P; Bianchi V Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13302-7. PubMed ID: 22847445 [TBL] [Abstract][Full Text] [Related]
60. Loss of cyclin g1 expression in human uterine leiomyoma cells induces apoptosis. Kwon SH; Park JC; Ramachandran S; Cha SD; Kwon KY; Park JK; Park JW; Bae I; Cho CH Reprod Sci; 2008 Apr; 15(4):400-10. PubMed ID: 18497347 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]